ServicesFrom preclinical to clinical: Leading explorer of drug-target interaction
Our ground-breaking, label-free technologies deployed under physiological or pathological environments allow us to offer innovative services of high added-value.
Inoviem Scientific offers a range of tailored services in the field of drug development.
Our technologies require no knowledge about your molecule and are able to identify any protein associated with your therapeutic target, even one as yet unidentified, within an interactome. Thus, they provide unbiased information about your drug and its natural environment.
During clinical phases, our label-free technologies are capable of analysing the impact of your drug on the molecular elasticity of crude tissue, whether healthy or diseased. The information obtained from the crude patient tissue enables us to identify, pre- and post-market, the sub-group of patients who will respond to a given drug.
These are the advantages of Inoviem’s solutions.